Flavia Lima, Andrea L. Silva , Maria L. R. P. D. Scoton, Elcio Brito, Eduardo Dias, Ronaldo Brito



Medicine Traceability Models and its Drivers: Some Insights from USA, European Union, Turkey, Argentina and Brazil

pdf PDF


In this paper the existing medicine traceability models in 4 countries and European Union are analyzed. The objective is to verify similarities and differences among the models regarding important criteria such as implementation phases, goals, governance, technologies and information flow. The study employed a review of existing literature on the theme and interviews with experts. The findings show that there is not a consensus about the best medicine traceability model around the world: each regulation has its own peculiarities. The government’s objectives - beside patient’s safety - play an important role on traceability model requirements. The authors also verified that, in spite of the advances motivated by new laws, organizations still have a lot of work to use traceability as a tool of supply chain management.


supply chain management, medicine traceability models, healthcare


[1] D. M. Lambert. An executive summary of supply chain management: processes, partnerships, performance. Sarasota: Supply Chain Management Institute (2008)

[2] ANMAT. Sistema de Trazabilidad de Pro. Médicos. Available at < http://www.anmat.gov.ar/trazabilidad _pm/Acercade.asp> Access: 06/17/2016

[3] T. Moe. Perspectives on traceability in food manufacture. Trends in Food Science & Technology, 9, 211-214 (1998)

[4] Investment Support and Promotion Agency of Turkey. The Pharmaceutical Industry in Turkey (2014). Available at < http://www.invest.gov.tr/enUS/infocenter/publications/Documents/PHAR MACEUTICAL.INDUSTRY.pdf> Access: 06/17/2016

[5] R. R. Lummus; R. J. Vokurka. Defining supply chain management: a historical perspective and practical guidelines. Industrial Management & Data Systems, 99, 1, 11-17 (1999)

[6] R. H. Ballou. The evolution and future of logistics and supply chain management. European Business Review, 19, 4, 332-348 (2007)

[7] W. L. Tate; D. Mollenkopf; T. Stank; A. L. da Silva. Integrating Supply and Demand. MIT Sloan Management Review, 56, 4, 16-18 (2015)

[8] N. Mai; S. Gretar; B.; S. Arason; S. Víkingur; Á. Thórólfur; G. Matthíasson. Benefits of traceability in fish supply chains – case studies. British Food Journal, 112, 9, 976-1002 (2010)

[9] GS1. Global Traceability for Healthcare. GS1, 1.2.0, 1-68 (2013)

[10] FDA. Drug Supply Chain Security Act – DSCSA (2016). Available at < http://www.fda.gov/Drugs /DrugSafety/DrugIntegrityandSupplyChainSec urity/DrugSupplyChainSecurityAct/>. Access: 06/15/2016

[11] Healthcare Distribution Alliance (HDA). Pharmaceutical traceability (2013). Available at < http://www.healthcaredistribution.org/issues/ph armaceutical-traceability>. Access: 06/15/2016

[12] FDA. Are you ready for the Drug Supply Chain Security Act? (2016). Available at . Access: 06/15/2016

[13] FDA. DSCSA Implementation: Product Tracing Requirements for Dispensers - Compliance Policy(Revised) (2015). Available at < http://www.fda.gov/downloads/Drugs/Guidanc eComplianceRegulatoryInformation/Guidances /UCM453225.pdf>. Access: 06/15/2016

[14] GS1. How Can GS1 Standards Help Your Company Meet Drug Supply Chain Security Act (DSCSA) Requirements? Available at: Access: 06/16/2016

[15] C. Jung, The Drug Supply Chain Security Act: Readiness and Implementation. Sheraton (2015). Available at: < http://www.fda.gov/downloads/drugs/developm entapprovalprocess/smallbusinessassistance/uc m445614.pdf> Access: 06/16/2016

[16] Johnson&Johnson. Serialization & Traceability Challenges and Opportunities in the Brazilian Scenario. Available at: http://www.gs1.org/sites/default/files /brazilian_serialization_johnson.pdf> Access: 06/16/2016

[17] Gilchrist. DSCSA Track-and-Trace: Next Steps for Pharmacists. Pharmacy Times (2015). Available at Access: 06/16/2016

[18] EFPIA. European Medicines Verification System (EMVS) (2013). Available at < http://www.efpia.eu /uploads/images/EFPIA%20European%20Pack %20Coding%20Guideline%20V3_6%20(Final) .pdf> Access: 06/16/2016

[19] European Commission. Falsified medicines. Available at < http://ec.europa.eu/health/humanuse/falsified_medicines/index_en.htm> Access: 06/16/2016

[20] EFPIA. Progress towards a European Medicines Verification System: the European Stakeholder Model and securPharm link-up (2014). Available at < http://www.efpia.eu/mediaroom/147/43/Progre ss-towards-a-European-MedicinesVerification-System-the-EuropeanStakeholder-Model-and-securPharm-link-up> Access: 06/16/2016

[21] C. Krähenbühl. Be ready for EU packaging safety regulations (2014). Pharmaphorum. Available at < http://pharmaphorum.com/views-andanalysis/be-ready-for-eu-packaging-safetyregulations/>. Access: 06/16/2016

[22] Delegated Acts on safety features (Regulation 2016/161) (2016)

[23] European Comission. Safety features for medicinal products for human use questions and answers, v 4.1 (2016). Available at < http://ec.europa.eu/health /files/falsified_medicines/qa_safetyfeature.pdf> Access: 06/16/2016

[24] L. Banks. EU stakeholders form medicines traceability organisation. Available at Access: 06/16/2016

[25] Kuzey Pharma. ITS (Turkish Pharmaceutical Track and Trace System) (2013). Available at < http://www.kuzeypharma.com/its-turkishpharmaceutical-track-and-trace-system/> Access: 06/17/2016

[26] Tiga. Pharmaceutical Track & Trace System tracks all drugs in Turkey in manufacturing, purchasing, sale and storage processes. Available at < http://www.tiga.com.tr/en/pharmaceuticaltrack-trace-system> Access: 06/17/2016

[27] GS1 Turkey. İTS –Turkish Pharmaceutical Track and Trace System (2013). Available at < http://www.gs1.org/docs/healthcare/Wed_9h25 _YelizGeris_Turkey.pdf> Access: 06/17/2016

[28] GS1. Successful cases of Traceability in the Healthcare Sector in Argentina (2014)

[29] F. Lopes. O setor farmacêutico tem até dezembro de 2016 para se adequar à regulamentação da ANVISA e adotar o código de barras bidimensional (2015). Available at < http://computerworld.com.br/entendarastreabilidade-de-medicamentos-no-brasil-emcinco-passos> Access 06/21/2016

[30] N. B. Hizmetleri. Case Study: Pharmaceutical Track And Trace System in Turkey. California: TechNarts & ITS (2013).

Cite this paper

Flavia Lima, Andrea L. Silva , Maria L. R. P. D. Scoton, Elcio Brito, Eduardo Dias, Ronaldo Brito. (2016) Medicine Traceability Models and its Drivers: Some Insights from USA, European Union, Turkey, Argentina and Brazil. International Journal of Economics and Management Systems, 1, 163-168


Copyright © 2017 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0